心理共病对肠易激综合征预后的影响
该纵向12个月随访研究纳入807名符合Rome IV标准的肠易激综合征(IBS)成人,基线评估心理共病数量,发现心理共病越多,IBS症状越重、就诊及治疗负担越高,12个月随访时症状严重度及日常活动影响随心理共病数量递增而恶化。
要点
- 心理共病数量与IBS基线症状严重度呈剂量依赖关系。
- 心理共病越多,12个月随访时就诊消化科及接受更多治疗的比例越高。
- 心理共病累积可预测IBS症状持续及日常活动受限。
核心结论
- Rome IV定义的IBS患者,其预后随心理共病数量的递增而逐步恶化。
研究设计与样本
- 纵向12个月随访研究,基线纳入807名符合Rome IV标准的IBS成人,12个月成功随访452人。
主要发现
- 基线时807名参与者中,心理共病数量为1、2、3、4、5种的比例分别为21.9%、17.2%、12.8%、11.0%、6.7%。
- 基线IBS症状严重度随心理共病数量增加而显著升高,5种共病者72.2%报告严重症状,无共病者为29.1%(P < 0.001)。
- 12个月随访的452人中,基线心理共病越多者看消化科的比例越高(5种共病33.3% vs 无共病21.4%,P = 0.001),接受更多治疗(P < 0.0001)。
- 12个月随访时,5种共病者报告严重IBS症状的比例为66.7%,无共病者为24.4%(P < 0.001);持续腹痛比例分别为61.9%和22.1%(P < 0.001)。
- 12个月随访时,5种共病者报告症状影响日常活动≥50%时间的比例为90.5%,无共病者为41.2%(P < 0.001)。
临床怎么用
- 临床评估IBS患者时应系统筛查心理共病,共病数量可用于预后分层。
- 对心理共病较多的IBS患者,可能需要更积极的综合管理及心理干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Psychological comorbidities are associated with irritable bowel syndrome (IBS), but little is known about their cumulative effect on its prognosis. We examined this issue in a longitudinal 12-month follow-up study. METHODS: We collected complete demographic, symptom, and psychological comorbidity data (anxiety, depression, somatic symptom disorder, perceived stress, and gastrointestinal symptom-specific anxiety) at baseline from 807 adults who met Rome IV criteria for IBS. At 12 months, we collected data regarding IBS symptom severity and impact, consultation behavior, and treatments commenced from 452 individuals successfully followed up. We examined the cumulative effects of psychological comorbidities at baseline on subsequent IBS disease behavior. RESULTS: At baseline, among the 807 participants, 177 (21.9%) had 1, 139 (17.2%) 2, 103 (12.8%) 3, 89 (11.0%) 4, and 54 (6.7%) 5 psychological comorbidities. IBS symptom severity at baseline increased significantly with the number of psychological comorbidities (72.2% of those with 5 psychological comorbidities reported severe symptoms, vs 29.1% of those with none, P < 0.001). Among 452 (56.0%) participants followed up at 12 months, those with a higher number of psychological comorbidities at baseline were significantly more likely to have seen a gastroenterologist (33.3% of those with 5 psychological comorbidities, vs 21.4% of those with none, P = 0.001), cycle through more treatments (P < 0.0001), to report more severe IBS symptoms (66.7% with 5, vs 24.4% with none, P < 0.001) and continuous abdominal pain (22.1% with none, vs 61.9% with 5, P < 0.001), and to report that symptoms impacted on daily activities ≥50% of the time (90.5% with 5, vs 41.2% with none, P < 0.001). DISCUSSION: The prognosis of individuals with Rome IV-defined IBS worsens according to incremental increases in psychological comorbidity. This has important clinical and research implications.
引用
- Goodoory VC, Mikocka-Walus A, Yiannakou Y, et al. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol. 2021. PMID: 33840729. doi:10.14309/ajg.0000000000001247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。